Lawmakers Urge MedPAC To Rethink Imaging Cuts
This article was originally published in The Gray Sheet
MedPAC's recent votes favoring policy changes intended to further reduce imaging utilization and spending are misguided, two lawmakers argue in a recent letter to the commission.
You may also be interested in...
MedPAC Forwards More Ideas To Reduce Advanced Imaging Spending
The Medicare Payment Advisory Commission outlined four draft recommendations last week intended to either reduce payments for or control use of advanced imaging tools. Among the ideas: a prior authorization program specifically targeting physicians who order the most imaging scans.
US FDA Complete Response Letter Rates Vary With Sponsor Size
Pink Sheet infographic illustrates benefits of big pharma’s resources and experience.
Is It Time To Promote US FDA’s Biosimilars Office Out Of OND?
Making the Office of Therapeutic Biologics and Biosimilars a stand-alone office in CDER may allow it to add more expertise, but is there an appetite for another reorganization?